PHS
WBA

PFM Health Sciences’s Walgreens Boots Alliance WBA Stock Holding History

PFM Health Sciences’s Portfolio WBA Stock Details WBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-645,665
Closed -$53.4M – 119
2016
Q4 		$53.4M Sell
645,665
-440,760
-41% -$36.4M 1.51% 24
2016
Q3 		$87.6M Buy
1,086,425
+254,238
+31% +$20.7M 2.56% 7
2016
Q2 		$69.3M Sell
832,187
-367,131
-31% -$29.6M 2.09% 13
2016
Q1 		$101M Sell
1,199,318
-1,067,878
-47% -$85.3M 3.12% 7
2015
Q4 		$193M Buy
2,267,196
+108,029
+5% +$9.18M 5.87% 2
2015
Q3 		$179M Buy
2,159,167
+587,146
+37% +$53.1M 5.05% 3
2015
Q2 		$133M Buy
1,572,021
+202,542
+15% +$17.5M 3.36% 6
2015
Q1 		$116M Sell
1,369,479
-413,341
-23% -$32.9M 3.2% 4
2014
Q4 		$136M Buy
+1,782,820
New +$119M 3.17% 5
2014
Q3 		– Sell
-2,499,165
Closed -$185M – 75
2014
Q2 		$185M Sell
2,499,165
-343,346
-12% -$24M 3.7% 7
2014
Q1 		$188M Buy
+2,842,511
New +$179M 3.4% 7

Other funds holding WBA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PFM Health Sciences's WBA Position: Q1 2017 in Review

PFM Health Sciences sold out of Walgreens Boots Alliance (WBA) in Q1 2017, closing a stake of 645,665 shares — an estimated $53.4M sold.

PFM Health Sciences first reported a position in WBA in Q1 2014 and held it in 11 quarters. The position peaked at $193M in Q4 2015. 1,307 funds tracked by Wall St. Rank hold WBA as of Q1 2017.

  • PFM Health Sciences reported no remaining Walgreens Boots Alliance position as of Q1 2017 after selling out during the quarter.
  • PFM Health Sciences sold 645,665 Walgreens Boots Alliance shares in Q1 2017, an estimated $53.4M.
  • PFM Health Sciences first reported a position in Walgreens Boots Alliance in Q1 2014 and held it in 11 quarters.
  • PFM Health Sciences's Walgreens Boots Alliance position peaked at $193M in Q4 2015.
  • 1,307 funds tracked by Wall St. Rank held Walgreens Boots Alliance as of Q1 2017.

Based on PFM Health Sciences's 13F filing for Q1 2017, filed 15 May 2017.